Scarica l'app Stockscreener
58.45
2.50%
-1.50
Pre-mercato:
58.41
-0.04
-0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Boston Scientific Corp Borsa (BSX) Ultime notizie
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
J&J starts head-to-head PFA trial against Boston Scientific device - Yahoo Finance
Boston Scientific stock hits 52-week low at 59.32 USD By Investing.com - Investing.com South Africa
Boston Scientific stock hits 52-week low at 59.32 USD - Investing.com
Massively Disappointing Boston Scientific (BSX) Stock Could Be Due for a Comeback - Barchart
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors - GlobeNewswire Inc.
Boston Scientific Corp (NYSE:BSX) Offers a Textbook Example of Affordable Growth - ChartMill
BSX Shareholders Have Opportunity to Lead Boston Scientific Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Boston Scientific Corp (BSX) Stock Down 3.4% -- Now Undervalued? GF Score: 85/100 - GuruFocus
Boston Scientific Q1 Beats but Outlook Misses: What’s Next for the Stock? - Moomoo
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch
BSX DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - TMX Newsfile
HRS 2026: Medtronic, Boston Scientific and Abbott debut key PFA data - Yahoo Finance
Boston Scientific Corp. Opens with 4.84% Gain, Outperforming S&P 500's 1.05% Increase - Markets Mojo
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
BSX DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific (BSX) Unveils Promising Results for Heart Tech - GuruFocus
One Boston Scientific heart device beat drug therapy in new trial data - Stock Titan
BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Calamos Wealth Management LLC Cuts Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Calamos Advisors LLC - MarketBeat
BSX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - TMX Newsfile
A Look at Boston Scientific Corp (BSX) After 5.5% Decline -- GF Value $104.55 vs Price $62.07 - GuruFocus
Boston Scientific Corp (BSX) Stock Price, Trades & News - GuruFocus
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific Corp Stock (BSX) Closed Down by 5.56% on Apr 24: Drivers Behind the Movement - TradingKey
Intuitive Surgical vs Boston Scientific: Which Stock Is the Better Buy Post Q1? - Yahoo Finance
Boston Scientific put volume heavy and directionally bearish - TipRanks
5 Early Q1 Earnings Winners Beating ExpectationsBoston Scientific (NYSE:BSX), GE Vernova (NYSE:GEV) - Benzinga
GE Vernova, Boston Scientific, Intuitive Surgical and other big stocks moving higher on Wednesday - MSN
How The Investment Story Is Resetting For Boston Scientific (BSX) After Recent Analyst Shifts - Yahoo Finance
Med tech company Boston Scientific readies for new Austin offices - MSN
BSX DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - TMX Newsfile
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Penumbra (PEN) urges shareholders to approve Boston Scientific merger May 6 - Stock Titan
Boston Scientific Analysts Slash Their Forecasts After Q1 Earnings - Benzinga
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Alleged Concealment of Electrophysiology Demand Weaknesses: SueWallSt – Company AnnouncementFT. - Financial Times
Teacher Retirement System of Texas Decreases Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Q1 2026 Earnings Call Transcript - Insider Monkey
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces a - GlobeNewswire
North Point Portfolio Managers Corp OH Buys New Shares in Boston Scientific Corporation $BSX - MarketBeat
Catheters Market Report 2025-2030, Profiles and Strategy - GlobeNewswire
Rothschild & Co Redburn Adjusts PT on Boston Scientific to $106 From $110, Maintains Buy Rating - marketscreener.com
Boston Scientific reports steady Q1 2026 performance yet tempers FY26 outlook - Medical Device Network
Truist cuts Boston Scientific stock price target on growth outlook - Investing.com
Boston Scientific beats Q1 expectations - medwatch.com
Boston Scientific Corp (BSX) Q1 2026 Earnings Call Highlights: S - GuruFocus
Is It Time To Reassess Boston Scientific (BSX) After Its Recent Share Price Slide - Yahoo Finance
Boston Scientific Faces Headwinds in 2026 That Could Mute Results, but Moat Remains Intact - Morningstar
BSX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific net sales up 11.6% to USD 5.203B in Q1 2026 - Medical Buyer
Boston Scientific Trial Wins And Approvals Contrast With Recent Share Weakness - simplywall.st
Boston Scientific Balances Strong Q1 With Softer Outlook - TipRanks
A Look at Boston Scientific Corp (BSX) After 9.0% Gain -- GF Val - GuruFocus
Canaccord cuts Boston Scientific stock price target on guidance reduction By Investing.com - Investing.com South Africa
Canaccord cuts Boston Scientific stock price target on guidance reduction - Investing.com
Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations - The Motley Fool
BSX Maintains Rating by Jefferies -- Price Target Lowered to $10 - GuruFocus
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):